A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Public ClinicalTrials.gov record NCT07142356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Study identification
- NCT ID
- NCT07142356
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Retension Pharmaceuticals. Inc.
- Industry
- Enrollment
- 280 participants
Conditions and interventions
Conditions
Interventions
- Matching placebo control Drug
- RTN-001 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 30, 2025
- Primary completion
- Sep 30, 2026
- Completion
- Apr 30, 2027
- Last update posted
- Apr 26, 2026
2025 – 2027
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retension Clinical Site | San Jose | California | 95128 | Recruiting |
| Retension Clinical Site | West Hills | California | 91307 | Recruiting |
| Retension Clinical Site | Waterbury | Connecticut | 06708 | Recruiting |
| Retension Clinical Site | Orlando | Florida | 32801 | Recruiting |
| Retension Clinical Site | Port Orange | Florida | 32127 | Recruiting |
| Retension Clinical Site | Tampa | Florida | 33606 | Recruiting |
| Retension Clinical Site | Lawrenceville | Georgia | 30044 | Recruiting |
| Retension Clincial Site | Boston | Massachusetts | 02131 | Recruiting |
| Retension Clinical Site | Las Vegas | Nevada | 89109 | Recruiting |
| Retension Clinical Site | Las Vegas | Nevada | 89121 | Recruiting |
| Retension Clinical Site | Asheboro | North Carolina | 27203 | Recruiting |
| Retension Clinical Site | Charlotte | North Carolina | 28210 | Recruiting |
| Retension Clinical Site | Monroe | North Carolina | 28112 | Recruiting |
| Retension Clinical Site | Cincinnati | Ohio | 45245 | Recruiting |
| Retension Clinical Site | Charleston | South Carolina | 29407 | Recruiting |
| Rretension clinical site | Bellaire | Texas | 77401 | Recruiting |
| Retension Clinical Site | Dallas | Texas | 75230 | Recruiting |
| Retension Clincal Site | Plano | Texas | 75024 | Recruiting |
| Retension Clinical Site | San Antonio | Texas | 78215 | Recruiting |
| Retension Clinical Site | Vienna | Virginia | 22182 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07142356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 26, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07142356 live on ClinicalTrials.gov.